BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 19027366)

  • 1. Bone health and osteoporosis in postmenopausal women.
    de Villiers TJ
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):73-85. PubMed ID: 19027366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for treatment to prevent fragility fractures in postmenopausal women.
    Geusens P
    Best Pract Res Clin Rheumatol; 2009 Dec; 23(6):727-40. PubMed ID: 19945685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to manage osteoporosis after the menopause.
    Compston J
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1007-19. PubMed ID: 16301194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis.
    Ebeling PR; Russell RG
    Int J Clin Pract; 2003 Oct; 57(8):710-8. PubMed ID: 14627183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF; Bowlby LA; McGarry K
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL; Chao HT; Cheng MH; Wang PH
    Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of women at risk for fracture and intervention with fast-acting therapies.
    Derman R
    Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2006; 13(3):340-67; quiz 368-9. PubMed ID: 16735931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of hormone replacement therapy on bone mineral content and on fractures].
    Eiken PA
    Ugeskr Laeger; 1997 Jan; 159(5):570-6. PubMed ID: 9045445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and prevention of osteoporosis-related fractures.
    Dontas IA; Yiannakopoulos CK
    J Musculoskelet Neuronal Interact; 2007; 7(3):268-72. PubMed ID: 17947811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
    Inderjeeth CA; Foo AC; Lai MM; Glendenning P
    Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and therapeutic aspects of osteoporosis.
    Compston J
    Eur J Radiol; 2009 Sep; 71(3):388-91. PubMed ID: 19660883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
    Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
    Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
    Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
    Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations on the management of fragility fracture risk in women younger than 70 years.
    Palacios S; Christiansen C; Sánchez Borrego R; Gambacciani M; Hadji P; Karsdal M; Lambrinoudaki I; Lello S; O'Beirne B; Romao F; Rozenberg S; Stevenson JC; Ben-Rafael Z
    Gynecol Endocrinol; 2012 Oct; 28(10):770-86. PubMed ID: 22558997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I;
    Clin Calcium; 2007 Jul; 17(7):1090-6. PubMed ID: 17607077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of postmenopausal osteoporosis.
    Murphy FT; Kivitz AJ; Sands EE
    J Am Osteopath Assoc; 2003 Oct; 103(10 Suppl 6):S6-11. PubMed ID: 14620079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis: strategies for prevention and management.
    Keen R
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):109-22. PubMed ID: 17350547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.